Chemoinformaics analysis of Furo[2,3-h]quinoline
| Molecular Weight | 169.183 | nRot | 0 |
| Heavy Atom Molecular Weight | 162.127 | nRig | 18 |
| Exact Molecular Weight | 169.053 | nRing | 3 |
| Solubility: LogS | -3.335 | nHRing | 2 |
| Solubility: LogP | 2.374 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 7 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 13 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 15 |
| nHA | 2 | APOL | 24.9396 |
| nHD | 0 | BPOL | 9.89845 |
| QED | 0.547 |
| Synth | 2.352 |
| Natural Product Likeliness | 0.673 |
| NR-PPAR-gamma | 0.088 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.007 |
| Pgp-sub | 0.002 |
| HIA | 0.01 |
| CACO-2 | -5.011 |
| MDCK | 0.0000175 |
| BBB | 0.039 |
| PPB | 0.990014 |
| VDSS | 0.501 |
| FU | 0.0126696 |
| CYP1A2-inh | 0.945 |
| CYP1A2-sub | 0.09 |
| CYP2c19-inh | 0.276 |
| CYP2c19-sub | 0.052 |
| CYP2c9-inh | 0.612 |
| CYP2c9-sub | 0.639 |
| CYP2d6-inh | 0.446 |
| CYP2d6-sub | 0.362 |
| CYP3a4-inh | 0.712 |
| CYP3a4-sub | 0.179 |
| CL | 11.1 |
| T12 | 0.907 |
| hERG | 0.021 |
| Ames | 0.804 |
| ROA | 0.88 |
| SkinSen | 0.919 |
| Carcinogencity | 0.782 |
| EI | 0.95 |
| Respiratory | 0.143 |
| NR-Aromatase | 0.792 |
| Antiviral | No |
| Prediction | 0.595563 |